Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.novartis.com/news/media-releases/novartis-bolsters-innovative-medicines-strategy-and-renal-pipeline-agreement-acquire-chinook-therapeutics-usd-32bn-upfront-usd-40-share
0
0
Novartis bolsters innovative medicines strategy and renal pipeline with agreement to acquire Chinook Therapeutics for USD 3.2bn upfront (USD 40 / share) - Novartis
6/12/23 at 5:05am
Organization
Novartis.com
Authors
Details
59 words
Summarize
Pharmaceuticals & Biotech
Business & Industrial
Drugs & Medications
Novartis
medicines strategy
Chinook Therapeutics
Art
LR
Swiss
Ad hoc announcement pursuant to Art. 53 LR Ad hoc announcement pursuant to Art. 53 LR Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...